109 related articles for article (PubMed ID: 32555515)
1. Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.
Powles T; Kockx M; Rodriguez-Vida A; Duran I; Crabb SJ; Van Der Heijden MS; Szabados B; Pous AF; Gravis G; Herranz UA; Protheroe A; Ravaud A; Maillet D; Mendez MJ; Suarez C; Linch M; Prendergast A; van Dam PJ; Stanoeva D; Daelemans S; Mariathasan S; Tea JS; Mousa K; Banchereau R; Castellano D
Nat Med; 2020 Jun; 26(6):983. PubMed ID: 32555515
[TBL] [Abstract][Full Text] [Related]
2. Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.
Powles T; Kockx M; Rodriguez-Vida A; Duran I; Crabb SJ; Van Der Heijden MS; Szabados B; Pous AF; Gravis G; Herranz UA; Protheroe A; Ravaud A; Maillet D; Mendez MJ; Suarez C; Linch M; Prendergast A; van Dam PJ; Stanoeva D; Daelemans S; Mariathasan S; Tea JS; Mousa K; Banchereau R; Castellano D
Nat Med; 2023 Dec; 29(12):3271. PubMed ID: 36944799
[No Abstract] [Full Text] [Related]
3. Re: Clinical Efficacy and Biomarker Analysis of Neoadjuvant Atezolizumab in Operable Urothelial Carcinoma in the ABACUS Trial.
Schulz GB; Black PC
Eur Urol; 2020 May; 77(5):652-653. PubMed ID: 32029339
[No Abstract] [Full Text] [Related]
4. Publisher Correction: The Technome - A Predictive Internal Calibration Approach for Quantitative Imaging Biomarker Research.
Mühlberg A; Katzmann A; Heinemann V; Kärgel R; Wels M; Taubmann O; Lades F; Huber T; Maurus S; Holch J; Faivre JB; Sühling M; Nörenberg D; Rémy-Jardin M
Sci Rep; 2020 Jul; 10(1):11442. PubMed ID: 32632285
[TBL] [Abstract][Full Text] [Related]
5. Publisher Correction: Soluble LRP1 is an independent biomarker of epicardial fat volume in patients with type 1 diabetes mellitus.
de Gonzalo-Calvo D; Colom C; Vilades D; Rivas-Urbina A; Moustafa AH; Pérez-Cuellar M; Sánchez-Quesada JL; Pérez A; LLorente-Cortes V
Sci Rep; 2019 Nov; 9(1):16715. PubMed ID: 31700093
[TBL] [Abstract][Full Text] [Related]
6. Publisher Correction: Analysis of Copy-Number Variations and Feline Mammary Carcinoma Survival.
Granados-Soler JL; Bornemann-Kolatzki K; Beck J; Brenig B; Schütz E; Betz D; Junginger J; Hewicker-Trautwein M; Murua Escobar H; Nolte I
Sci Rep; 2020 Mar; 10(1):5482. PubMed ID: 32198396
[TBL] [Abstract][Full Text] [Related]
7. Publisher Correction: Circulating serum HBsAg level is a biomarker for HBV-specific T and B cell responses in chronic hepatitis B patients.
Kim JH; Ghosh A; Ayithan N; Romani S; Khanam A; Park JJ; Rijnbrand R; Tang L; Sofia MJ; Kottilil S; Moore CB; Poonia B
Sci Rep; 2020 Mar; 10(1):5947. PubMed ID: 32231233
[TBL] [Abstract][Full Text] [Related]
8. Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancer.
Middleton G; Fletcher P; Popat S; Savage J; Summers Y; Greystoke A; Gilligan D; Cave J; O'Rourke N; Brewster A; Toy E; Spicer J; Jain P; Dangoor A; Mackean M; Forster M; Farley A; Wherton D; Mehmi M; Sharpe R; Mills TC; Cerone MA; Yap TA; Watkins TBK; Lim E; Swanton C; Billingham L
Nature; 2020 Sep; 585(7826):E21. PubMed ID: 32887973
[TBL] [Abstract][Full Text] [Related]
9. Publisher Correction: A clonal expression biomarker associates with lung cancer mortality.
Biswas D; Birkbak NJ; Rosenthal R; Hiley CT; Lim EL; Papp K; Boeing S; Krzystanek M; Djureinovic D; La Fleur L; Greco M; Döme B; Fillinger J; Brunnström H; Wu Y; Moore DA; Skrzypski M; Abbosh C; Litchfield K; Al Bakir M; Watkins TBK; Veeriah S; Wilson GA; Jamal-Hanjani M; Moldvay J; Botling J; Chinnaiyan AM; Micke P; Hackshaw A; Bartek J; Csabai I; Szallasi Z; Herrero J; McGranahan N; Swanton C;
Nat Med; 2020 Jul; 26(7):1148. PubMed ID: 32494065
[TBL] [Abstract][Full Text] [Related]
10. Publisher Correction: Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality.
Lee YB; Nam JY; Lee JH; Chang Y; Cho H; Cho YY; Cho EJ; Yu SJ; Kim HY; Lee DH; Lee JM; Hwang SG; Kim YJ; Yoon JH
Sci Rep; 2019 Aug; 9(1):12146. PubMed ID: 31420563
[TBL] [Abstract][Full Text] [Related]
11. Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis.
Brastianos PK; Lee EQ; Cohen JV; Tolaney SM; Lin NU; Wang N; Chukwueke U; White MD; Nayyar N; Kim A; Alvarez-Breckenridge C; Krop I; Mahar MK; Bertalan MS; Shaw B; Mora JL; Goss N; Subramanian M; Nayak L; Dietrich J; Forst DA; Nahed BV; Batchelor TT; Shih HA; Gerstner ER; Moy B; Lawrence D; Giobbie-Hurder A; Carter SL; Oh K; Cahill DP; Sullivan RJ
Nat Med; 2020 Aug; 26(8):1309. PubMed ID: 32555425
[TBL] [Abstract][Full Text] [Related]
12. Publisher Correction: Prioritizing target-disease associations with novel safety and efficacy scoring methods.
Failli M; Paananen J; Fortino V
Sci Rep; 2020 Jan; 10(1):1885. PubMed ID: 32005882
[TBL] [Abstract][Full Text] [Related]
13. Author Correction: NICE's rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good?
Gupta S; Kamat AM
Nat Rev Urol; 2020 Sep; 17(9):540. PubMed ID: 32719534
[TBL] [Abstract][Full Text] [Related]
14. Publisher Correction: Different exercise training modalities produce similar endothelial function improvements in individuals with prehypertension or hypertension: a randomized clinical trial.
Pedralli ML; Marschner RA; Kollet DP; Neto SG; Eibel B; Tanaka H; Lehnen AM
Sci Rep; 2020 Jun; 10(1):10564. PubMed ID: 32581275
[TBL] [Abstract][Full Text] [Related]
15. Publisher Correction: Propolis-based niosomes as oromuco-adhesive films: A randomized clinical trial of a therapeutic drug delivery platform for the treatment of oral recurrent aphthous ulcers.
Arafa MG; Ghalwash D; El-Kersh DM; Elmazar MM
Sci Rep; 2020 Feb; 10(1):2459. PubMed ID: 32034286
[TBL] [Abstract][Full Text] [Related]
16. Publisher Correction: Use of reliable contraceptives and its correlates among women participating in Simulated HIV vaccine efficacy trials in key-populations in Uganda.
Abaasa A; Todd J; Mayanja Y; Price M; Fast PE; Kaleebu P; Nash S
Sci Rep; 2019 Nov; 9(1):18274. PubMed ID: 31784698
[TBL] [Abstract][Full Text] [Related]
17. Publisher Correction: Cortical encoding of speech enhances task-relevant acoustic information.
Rutten S; Santoro R; Hervais-Adelman A; Formisano E; Golestani N
Nat Hum Behav; 2019 Oct; 3(10):1125. PubMed ID: 31462763
[TBL] [Abstract][Full Text] [Related]
18. Publisher Correction: A randomized controlled trial of restorative justice-informed treatment for domestic violence crimes.
Mills LG; Barocas B; Butters RP; Ariel B
Nat Hum Behav; 2019 Dec; 3(12):1344. PubMed ID: 31576024
[TBL] [Abstract][Full Text] [Related]
19. Publisher Correction: Metabolic phenotype of breast-fed infants, and infants fed standard formula or bovine MFGM supplemented formula: a randomized controlled trial.
He X; Parenti M; Grip T; Domellöf M; Lönnerdal B; Hernell O; Timby N; Slupsky CM
Sci Rep; 2019 Aug; 9(1):12382. PubMed ID: 31434987
[TBL] [Abstract][Full Text] [Related]
20. FDA Approval Summary: Atezolizumab for the Treatment of Patients with Progressive Advanced Urothelial Carcinoma after Platinum-Containing Chemotherapy.
Ning YM; Suzman D; Maher VE; Zhang L; Tang S; Ricks T; Palmby T; Fu W; Liu Q; Goldberg KB; Kim G; Pazdur R
Oncologist; 2017 Jun; 22(6):743-749. PubMed ID: 28424325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
